Tianjin Anding Hospital
32
7
7
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 32 trials
100.0%
+13.5% vs industry average
9%
3 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
Investigation on Suicide Risk Factors of Patients With Mood Disorders
Role: lead
Cognitive Impairment Characteristics and Biological Mechanisms in Untreated Severe Mental Illness
Role: lead
Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression
Role: lead
PQQ for Cognitive and Negative Symptoms
Role: lead
Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
Role: lead
Berberine Improving Cognitive Impairments in Schizophrenia
Role: lead
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
Role: lead
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
Role: collaborator
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Role: lead
Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia
Role: lead
Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
Role: collaborator
Amygdala TIS for Depression
Role: collaborator
TACS on High-inflammatory and Refractory Depression
Role: lead
Transcranial Alternating Current Stimulation for Treatment-Resistant Depression
Role: collaborator
Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes
Role: collaborator
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
Role: collaborator
Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia
Role: lead
Exosome for Early Diagnosis of Bipolar Affective Disorder
Role: lead
tDCS Combined With rTMS for Negative Symptoms of Schizophrenia
Role: lead
A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
Role: collaborator